378 related articles for article (PubMed ID: 26089168)
1. Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.
Miyazaki T; Kohno S
Expert Rev Anti Infect Ther; 2015; 13(9):1171-83. PubMed ID: 26089168
[TBL] [Abstract][Full Text] [Related]
2. Candida glabrata--unique features and challenges in the clinical management of invasive infections.
Glöckner A; Cornely OA
Mycoses; 2015 Aug; 58(8):445-50. PubMed ID: 26207423
[TBL] [Abstract][Full Text] [Related]
3. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.
Pfaller MA
Am J Med; 2012 Jan; 125(1 Suppl):S3-13. PubMed ID: 22196207
[TBL] [Abstract][Full Text] [Related]
4. Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU.
Coyle EA
J Pharm Pract; 2010 Feb; 23(1):33-7. PubMed ID: 21507791
[TBL] [Abstract][Full Text] [Related]
5. Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.
Arendrup MC; Patterson TF
J Infect Dis; 2017 Aug; 216(suppl_3):S445-S451. PubMed ID: 28911043
[TBL] [Abstract][Full Text] [Related]
8. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
[TBL] [Abstract][Full Text] [Related]
9. Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata.
Vella A; De Carolis E; Mello E; Perlin DS; Sanglard D; Sanguinetti M; Posteraro B
Sci Rep; 2017 Aug; 7(1):9099. PubMed ID: 28831086
[TBL] [Abstract][Full Text] [Related]
10. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
[TBL] [Abstract][Full Text] [Related]
11. The role of antifungal susceptibility testing in the therapy of candidiasis.
Hospenthal DR; Murray CK; Rinaldi MG
Diagn Microbiol Infect Dis; 2004 Mar; 48(3):153-60. PubMed ID: 15023422
[TBL] [Abstract][Full Text] [Related]
12. Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases.
Nami S; Aghebati-Maleki A; Morovati H; Aghebati-Maleki L
Biomed Pharmacother; 2019 Feb; 110():857-868. PubMed ID: 30557835
[TBL] [Abstract][Full Text] [Related]
13. The current treatment landscape: candidiasis.
Bassetti M; Peghin M; Timsit JF
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii13-ii22. PubMed ID: 27880665
[TBL] [Abstract][Full Text] [Related]
14. A Review on Molecular Mechanisms of Antifungal Resistance in
Lotfali E; Fattahi A; Sayyahfar S; Ghasemi R; Rabiei MM; Fathi M; Vakili K; Deravi N; Soheili A; Toreyhi H; Shirvani F
Microb Drug Resist; 2021 Oct; 27(10):1371-1388. PubMed ID: 33956513
[No Abstract] [Full Text] [Related]
15. Antifungal stewardship in invasive Candida infections.
Ruhnke M
Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():11-8. PubMed ID: 24661820
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of ibrexafungerp for the treatment of invasive candidiasis: the evidence to date.
Colombo RE; Vazquez JA
Expert Opin Pharmacother; 2021 May; 22(7):797-807. PubMed ID: 33599551
[TBL] [Abstract][Full Text] [Related]
17. Treatment of invasive candidiasis: between guidelines and daily clinical practice.
Tagliaferri E; Menichetti F
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):685-9. PubMed ID: 25818660
[TBL] [Abstract][Full Text] [Related]
18. Azole resistant Candida glabrata vulvovaginitis treated with boric acid.
Savini V; Catavitello C; Bianco A; Balbinot A; D'Antonio F; D'Antonio D
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):112. PubMed ID: 19619928
[No Abstract] [Full Text] [Related]
19. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design.
Lepak AJ; Zhao M; VanScoy B; Ambrose PG; Andes DR
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203480
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological advances in the treatment of invasive candidiasis.
Deck DH; Guglielmo BJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
